about
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing...
Read More
29.68
-1.26
(-4.07%)
813.6K
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for UroGen Pharma Ltd is on 19 May 2026 for the purpose of HC Wainwright 4(th) Annual BioConnect Investor Conference
See details
Not Eligible
Expensive Valuation
Technically Bullish
UroGen Pharma Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..